Vascular diseases: aortitis, aortic aneurysms, and vascular calcification

Cardiovascular Pathology

Volumn 25, Issue 5, 2016, Pages 432-441

  Ladich, Elena ^a   Yahagi, Kazuyuki ^a   Romero, Maria E ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

Author keywords

Aortic aneurysms; Aortitis; Calcification

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ANKYLOSING SPONDYLITIS; AORTA ANEURYSM; AORTA ATHEROSCLEROSIS; AORTITIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; DISEASE MODEL; EOSINOPHILIC GRANULOMA; EXTRACELLULAR MATRIX; GENETIC SCREENING; HUMAN; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; REITER SYNDROME; REVIEW; RHEUMATOID ARTHRITIS; THORACOABDOMINAL AORTA ANEURYSM; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTIC ANEURYSM; AORTIC VALVE; PATHOLOGY;

AORTIC ANEURYSM; AORTIC VALVE; AORTITIS; HUMANS; VASCULAR CALCIFICATION;

EID: 84981516841     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2016.07.002     Document Type: Review

References (82)

1. [1] Stone, JR, Bruneval, P, Angelini, A, Bartoloni, G, Basso, C, Batoroeva, L, et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 24 (2015), 267–278.
2. [2] Beckman, JA, Aortic aneurysms: pathophysiology, epidemiology, and prognosis. Creager, M.A., Dazu, V.J., Loscalzo, J., (eds.) Vascular medicine, 2006, Saunders Elsevier, Inc., Philadelphia.
3. [3] Kochanek, KD, Xu, J, Murphy, SL, Minino, AM, Kung, HC, Deaths: final data for 2009. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 60, 2011, 1–116.
4. [4] Halushka, MK, Single gene disorders of the aortic wall. Cardiovasc Pathol 21 (2012), 240–244.
5. [5] Halushka, MK, Angelini, A, Bartoloni, G, Basso, C, Batoroeva, L, Bruneval, P, et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the association for European cardiovascular pathology: II. Noninflammatory degenerative diseases—nomenclature and diagnostic criteria. Cardiovasc Pathol 25 (2016), 247–257.
6. [6] Demer, LL, Tintut, Y, Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol 34 (2014), 715–723.
7. [7] van Dijk, RA, Virmani, R, von der Thusen, JH, Schaapherder, AF, Lindeman, JH, The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region. Atherosclerosis 210 (2010), 100–106.
8. [8] Jennette, JC, Falk, RJ, Bacon, PA, Basu, N, Cid, MC, Ferrario, F, et al. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65 (2013), 1–11.
9. [9] Burke, AP, Tavora, F, Narula, N, Tomaszewski, JE, Virmani, R, Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histologic classification. Hum Pathol 39 (2008), 514–526.
10. [10] Miller, DV, Isotalo, PA, Weyand, CM, Edwards, WD, Aubry, MC, Tazelaar, HD, Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 30 (2006), 1150–1158.
11. [11] Rojo-Leyva, F, Ratliff, NB, Cosgrove, DM, Hoffman, GS, Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 43 (2000), 901–907.
12. [12] Gonzalez-Gay, MA, Pineiro, A, Gomez-Gigirey, A, Garcia-Porrua, C, Pego-Reigosa, R, Dierssen-Sotos, T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine 83 (2004), 342–347.
13. [13] Zehr, KJ, Mathur, A, Orszulak, TA, Mullany, CJ, Schaff, HV, Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg 79 (2005), 1512–1517.
14. [14] Odeh, M, Oliven, A, Temporal arteritis associated with acute Q fever. A case report. Angiology 45 (1994), 1053–1057.
15. [15] Hellmann, DB, Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, temporal arteritis, polymyalgia rheumatica, and Takayasu's arteritis. Curr Opin Rheumatol 5 (1993), 25–32.
16. [16] Klein, RG, Hunder, GG, Stanson, AW, Sheps, SG, Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 83 (1975), 806–812.
17. [17] Kerr, GS, Hallahan, CW, Giordano, J, Leavitt, RY, Fauci, AS, Rottem, M, et al. Takayasu arteritis. Ann Intern Med 120 (1994), 919–929.
18. [18] Park, MC, Lee, SW, Park, YB, Chung, NS, Lee, SK, Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34 (2005), 284–292.
19. [19] Siddiquee, Z, Zane, NA, Smith, RN, Stone, JR, Dense IgG4 plasma cell infiltrates associated with chronic infectious aortitis: implications for the diagnosis of IgG4-related disease. Cardiovasc Pathol 21 (2012), 470–475.
20. [20] Corradi, D, Nicastro, M, Vaglio, A, Immunoglobulin G4-related disease: some missing pieces in a still unsolved complex puzzle. Cardiovasc Pathol 25 (2016), 90–92.
21. [21] Bickerstaff, LK, Pairolero, PC, Hollier, LH, Melton, LJ, Van Peenen, HJ, Cherry, KJ, et al. Thoracic aortic aneurysms: a population-based study. Surgery 92 (1982), 1103–1108.
22. [22] Lederle, FA, Johnson, GR, Wilson, SE, Chute, EP, Littooy, FN, Bandyk, D, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 126 (1997), 441–449.
23. [23] Clouse, WD, Hallett, JW, Schaff, HV, Gayari, MM, Ilstrup, DM, Melton, LJ, Improved prognosis of thoracic aortic aneurysms: a population-based study. JAMA 280 (1998), 1926–1929.
24. [24] Cooley, DA, Annuloaortic ectasia. Ann Thorac Surg 28 (1979), 303–304.
25. [25] Isselbacher, EM, Thoracic and abdominal aortic aneurysms. Circulation 111 (2005), 816–828.
26. [26] Elefteriades, JA, Farkas, EA, Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol 55 (2010), 841–857.
27. [27] Hiratzka, LF, Bakris, GL, Beckman, JA, Bersin, RM, Carr, VF, Casey, DE, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121 (2010), e266–e369.
28. [28] Homme, JL, Aubry, MC, Edwards, WD, Bagniewski, SM, Shane Pankratz, V, Kral, CA, et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 30 (2006), 1159–1168.
29. [29] Guo, DC, Papke, CL, He, R, Milewicz, DM, Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 1085 (2006), 339–352.
30. [30] Coady, MA, Davies, RR, Roberts, M, Goldstein, LJ, Rogalski, MJ, Rizzo, JA, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 134 (1999), 361–367.
31. [31] Isselbacher, EM, Lino Cardenas, CL, Lindsay, ME, Hereditary influence in thoracic aortic aneurysm and dissection. Circulation 133 (2016), 2516–2528.
32. [32] Loeys, BL, Dietz, HC, Braverman, AC, Callewaert, BL, De Backer, J, Devereux, RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 47 (2010), 476–485.
33. [33] Cook, JR, Carta, L, Galatioto, J, Ramirez, F, Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes. Clin Genet 87 (2015), 11–20.
34. [34] Romaniello, F, Mazzaglia, D, Pellegrino, A, Grego, S, Fiorito, R, Ferlosio, A, et al. Aortopathy in Marfan syndrome: an update. Cardiovasc Pathol 23 (2014), 261–266.
35. [35] Jondeau, G, Boileau, C, Familial thoracic aortic aneurysms. Curr Opin Cardiol 29 (2014), 492–498.
36. [36] Byers, P, Disorders of collagen biosynthesis and structure. Scriver, C., Beaudet, A., Sly, W., Valle, D., (eds.) The metabolic and molecular bases of inherited diseases, 1995, McGraw-Hill, New York, 4029.
37. [37] Wenstrup, RJ, Meyer, RA, Lyle, JS, Hoechstetter, L, Rose, PS, Levy, HP, et al. Prevalence of aortic root dilation in the Ehlers–Danlos syndrome. Genet Med 4 (2002), 112–117.
38. [38] Loeys, BL, Chen, J, Neptune, ER, Judge, DP, Podowski, M, Holm, T, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37 (2005), 275–281.
39. [39] Loeys, BL, Schwarze, U, Holm, T, Callewaert, BL, Thomas, GH, Pannu, H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355 (2006), 788–798.
40. [40] Tran-Fadulu, V, Pannu, H, Kim, DH, Vick, GW, Lonsford, CM, Lafont, AL, et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 46 (2009), 607–613.
41. [41] Lederle, FA, In the clinic. Abdominal aortic aneurysm. Ann Intern Med, 150, 2009 [ITC5-1-15; quiz ITC5-6].
42. [42] Lederle, FA, Johnson, GR, Wilson, SE, Abdominal aortic aneurysm in women. J Vasc Surg 34 (2001), 122–126.
43. [43] Lederle, FA, Johnson, GR, Wilson, SE, Chute, EP, Hye, RJ, Makaroun, MS, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 160 (2000), 1425–1430.
44. [44] Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346 (2002), 1445–1452.
45. [45] Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK small aneurysm trial participants. Lancet 352 (1998), 1649–1655.
46. [46] Lederle, FA, Johnson, GR, Wilson, SE, Ballard, DJ, Jordan, WD, Blebea, J, et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 287 (2002), 2968–2972.
47. [47] Chaikof, EL, Brewster, DC, Dalman, RL, Makaroun, MS, Illig, KA, Sicard, GA, et al. SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg 50 (2009), 880–896.
48. [48] Brewster, DC, Cronenwett, JL, Hallett, JW, Johnston, KW, Krupski, WC, Matsumura, JS, Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 37 (2003), 1106–1117.
49. [49] Tilson, MD, Ozsvath, KJ, Hirose, H, Xia, S, A genetic basis for autoimmune manifestations in the abdominal aortic aneurysm resides in the MHC class II locus DR-beta-1. Ann N Y Acad Sci 800 (1996), 208–215.
50. [50] Roberts, WC, Ko, JM, Pearl, GJ, Relation of weights of intraaneurysmal thrombi to maximal right-to-left diameters of abdominal aortic aneurysms. Am J Cardiol 98 (2006), 1519–1524.
51. [51] Sun, J, Sukhova, GK, Zhang, J, Chen, H, Sjoberg, S, Libby, P, et al. Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 32 (2012), 15–23.
52. [52] Thompson, RW, Parks, WC, Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 800 (1996), 157–174.
53. [53] Trimarchi, S, Tsai, T, Eagle, KA, Isselbacher, EM, Froehlich, J, Cooper, JV, et al. Acute abdominal aortic dissection: insight from the International Registry of Acute Aortic Dissection (IRAD). J Vasc Surg 46 (2007), 913–919.
54. [54] Roberts, CS, Roberts, WC, Aortic dissection with the entrance tear in abdominal aorta. Am Heart J 121 (1991), 1834–1835.
55. [55] Larson, EW, Edwards, WD, Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 53 (1984), 849–855.
56. [56] Roberts, CS, Roberts, WC, Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol 17 (1991), 712–716.
57. [57] Meszaros, I, Morocz, J, Szlavi, J, Schmidt, J, Tornoci, L, Nagy, L, et al. Epidemiology and clinicopathology of aortic dissection. Chest 117 (2000), 1271–1278.
58. [58] Greenland, P, LaBree, L, Azen, SP, Doherty, TM, Detrano, RC, Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291 (2004), 210–215.
59. [59] Taylor, AJ, Bindeman, J, Feuerstein, I, Cao, F, Brazaitis, M, O'Malley, PG, Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol 46 (2005), 807–814.
60. [60] Allison, MA, Hsi, S, Wassel, CL, Morgan, C, Ix, JH, Wright, CM, et al. Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol 32 (2012), 140–146.
61. [61] Bos, D, Leening, MJ, Kavousi, M, Hofman, A, Franco, OH, van der Lugt, A, et al. Comparison of atherosclerotic calcification in major vessel beds on the risk of all-cause and cause-specific mortality: the Rotterdam study. Circ Cardiovasc Imaging, 8, 2015.
62. [62] Speer, MY, Giachelli, CM, Regulation of cardiovascular calcification. Cardiovasc Pathol 13 (2004), 63–70.
63. [63] Burke, AP, Weber, DK, Kolodgie, FD, Farb, A, Taylor, AJ, Virmani, R, Pathophysiology of calcium deposition in coronary arteries. Herz 26 (2001), 239–244.
64. [64] Otsuka, F, Sakakura, K, Yahagi, K, Joner, M, Virmani, R, Has our understanding of calcification in human coronary atherosclerosis progressed?. Arterioscler Thromb Vasc Biol 34 (2014), 724–736.
65. [65] Vengrenyuk, Y, Carlier, S, Xanthos, S, Cardoso, L, Ganatos, P, Virmani, R, et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci U S A 103 (2006), 14678–14683.
66. [66] Kelly-Arnold, A, Maldonado, N, Laudier, D, Aikawa, E, Cardoso, L, Weinbaum, S, Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc Natl Acad Sci U S A 110 (2013), 10741–10746.
67. [67] Mauriello, A, Servadei, F, Zoccai, GB, Giacobbi, E, Anemona, L, Bonanno, E, et al. Coronary calcification identifies the vulnerable patient rather than the vulnerable plaque. Atherosclerosis 229 (2013), 124–129.
68. [68] Sangiorgi, G, Rumberger, JA, Severson, A, Edwards, WD, Gregoire, J, Fitzpatrick, LA, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31 (1998), 126–133.
69. [69] Burke, AP, Farb, A, Pestaner, J, Malcom, GT, Zieske, A, Kutys, R, et al. Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks. Circulation 105 (2002), 419–424.
70. [70] Soor, GS, Vukin, I, Leong, SW, Oreopoulos, G, Butany, J, Peripheral vascular disease: who gets it and why? A histomorphological analysis of 261 arterial segments from 58 cases. Pathology 40 (2008), 385–391.
71. [71] Micheletti, RG, Fishbein, GA, Currier, JS, Fishbein, MC, Monckeberg sclerosis revisited: a clarification of the histologic definition of Monckeberg sclerosis. Arch Pathol Lab Med 132 (2008), 43–47.
72. [72] Lanzer, P, Boehm, M, Sorribas, V, Thiriet, M, Janzen, J, Zeller, T, et al. Medial vascular calcification revisited: review and perspectives. Eur Heart J 35 (2014), 1515–1525.
73. [73] Leopold, JA, Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med 25 (2015), 267–274.
74. [74] Pai, A, Leaf, EM, El-Abbadi, M, Giachelli, CM, Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol 178 (2011), 764–773.
75. [75] Speer, MY, Yang, HY, Brabb, T, Leaf, E, Look, A, Lin, WL, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 104 (2009), 733–741.
76. [76] Markello, TC, Pak, LK, St Hilaire, C, Dorward, H, Ziegler, SG, Chen, MY, et al. Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum. Mol Genet Metab 103 (2011), 44–50.
77. [77] Rutsch, F, Nitschke, Y, Terkeltaub, R, Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel. Circ Res 109 (2011), 578–592.
78. [78] Adar, A, Erkan, H, Gokdeniz, T, Karadeniz, A, Cavusoglu, IG, Onalan, O, Aortic arch calcification is strongly associated with coronary artery calcification. VASA 44 (2015), 106–114.
79. [79] Abramowitz, Y, Jilaihawi, H, Chakravarty, T, Mack, MJ, Makkar, RR, Porcelain aorta: a comprehensive review. Circulation 131 (2015), 827–836.
80. [80] Eisen, A, Tenenbaum, A, Koren-Morag, N, Tanne, D, Shemesh, J, Imazio, M, et al. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation 118 (2008), 1328–1334.
81. [81] Rodes-Cabau, J, Webb, JG, Cheung, A, Ye, J, Dumont, E, Feindel, CM, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55 (2010), 1080–1090.
82. [82] Fukuda, I, Daitoku, K, Minakawa, M, Fukuda, W, Shaggy and calcified aorta: surgical implications. Gen Thorac Cardiovasc Surg 61 (2013), 301–313.